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Smokers from lower socioeconomic groups are less likely to be successful in stopping smoking than more affluent smokers,
even after accessing cessation programmes. Data were analysed from 3057 clients of nine services. Routine monitoring data were
expanded with CO validated smoking status at 52-week follow-up. Backwards logistic regression modelling was used to consider
which factors were most important in explaining the relationship between SES and quitting. The odds ratio of stopping smoking
among more affluent clients, compared with more disadvantaged clients, after taking into account design variables only, was 1.85
(95% CI 1.44 to 2.37) which declined to 1.44 (1.11 to 1.87) when all controls were included. The factors that explained more than
10% of the decline in the odds ratio were age, proportion of friends and family who smoked, nicotine dependence, and taking
varenicline. A range of factors contribute to lower cessation rates for disadvantaged smokers. Some of these can be modified by
improved smoking cessation service provision, but others require contributions from wider efforts to improve material, human,
and social capital.
1. Introduction
In this paper, we explore why smoking cessation rates among
lower socioeconomic status (SES) smokers are poorer than
those of higher SES smokers.The study focuses on adults who
accessed stop smoking services in England. To contextualise
our work, we first introduce SES and the relationship between
SES and health. Using data collected from services, we then
explore the relationship between SES and smoking, smoking
cessation, and behavioural support.
SES can be described as the position of a person in the
structure of society due to social or economic factors [1].
There is no single measure of SES [1] but SES embodies
an array of resources: material capital such as money and
goods, human capital such as skills, knowledge, prestige
or power, and social capital—beneficial social connections
[2–4]. Building upon Coleman’s Social Theory [4], Oakes
and Rossi [3] suggest that SES should be assessed through
measures of material capital including measures of income
and housing status [3], measures of human capital including
measures of education and occupation [3] and measures of
beneficial social connections such as measures of marital
status and two parents rather than a single parent [1].
These material, human and social resources can be
deployed in order to promote health [2, 3]. The theory of
fundamental causes [2] posits that SES can be a cause of
poor health because it can be persistent over time and it
influences multiple disease outcomes, through disease risk
factors and mechanisms. These include demographic differ-
ences, psychological factors, access to medical care, social
environment, exposure to carcinogens and pathogens, CNS
and endocrine response, and health behaviours [5]. Health
behaviours have been found to be an important mechanism:
together, smoking, physical activity, and consuming alcohol
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have been found to explain 68% [6] of themortality difference
between low SES groups. Tobacco use alone has been found
to be responsible for 50 to 65% of the difference in mortality
rates based on socioeconomic status [7, 8]. This is because
smoking rates are higher among those with lower SES in the
majority of developed countries [9] and also in many low
and middle income countries [10]. Despite an overall decline
in smoking rates in the developed world, declines have been
slower or nonexistent amongst disadvantaged groups, thus
increasing inequalities [11–18].
Smoking prevalence may decline through lower uptake
of smoking and through smoking cessation. However, disad-
vantaged smokers have higher rates of uptake and lower rates
of successfully stopping [19–25] and findings from studies
examining SES and intention to quit are inconsistent [23,
26]. It appears that, in England at least, recent declines in
prevalence may be more to do with reduced uptake rather
than increased quittingwith quit rates possibly even declining
among more disadvantaged groups [17]. Therefore, in order
to improve the chances of current smokers successfully
stopping, we need to increase our understanding of why low
SES smokers find stopping smoking more difficult and use
this to inform policies and interventions. A recent review
[10] concludes that some disadvantaged smokers have more
stressful lives due to material hardship (or in other terms
less material capital): psychological differences and greater
dependence on tobacco coupled with less motivation to quit
(even when they have embarked on a quit attempt) and a
higher rate of smoking among family and friends (or less
social capital related to smoking).
SES differences in quit rates have also been observed in
studies of smoking cessation interventions [27–29]. Reviews
of the evidence suggest that the most promising tobacco
control interventions to reduce smoking rates among disad-
vantaged smokers are fiscal measures, in particular tobacco
taxation. However, there is also evidence to suggest that
individual level smoking cessation programmes providing
a combination of both pharmacotherapy and structured
behavioural support have some success among disadvantaged
smokers [30–32]. Smoking cessation quit rates are poorer for
disadvantaged smokers but this can be mitigated by focusing
resources on these communities [30]. In countries where
smoking cessation services are widely available and have
successfully targeted disadvantaged groups (such as in the
UK) [33], inequalities have not yet declined although they
may have stabilised [34, 35]. Ideally, however, quit rates would
be similar in all social groups so it would be helpful to find
out why there are differences between socioeconomic groups
taking part in such programmes.
In a previous paper [36] we used data from two longer
term evaluations of Stop Smoking Services in the UK to
examine the relationship between SES and quitting.Themain
factor associated with an unsuccessful quit attempt amongst
disadvantaged clients, in addition to dependence and social
networks, was not adhering to treatment (a stop smoking
programme including access to medication and behavioural
support). However, it is possible that inclusion of adherence
in the model in our study was merely a reflection of quitting
given that clients who relapse would tend to stop taking
medication and attending sessions; this would imply that
adherence differencesmay bemasking underlying reasons for
the difference in quit rates between disadvantaged and more
affluent smokers. Thus, a new analysis is needed using more
recent data.
The purpose of this paper is threefold. First, to explore
whether material, human, and social capital-related indica-
tors of SES are associated with smoking cessation amongst
clients of smoking cessation services in England, second, to
explore which material, human, and social capital related
predictors of cessation are associated with SES, and third, to
explore whether predictors of cessation explain why there is a
relationship between SES and successfully stopping smoking.
2. Methods
2.1. Data. This paper reports results from a prospective
cohort study involving longer term follow-up of smokers
accessing Stop Smoking Services in England (ELONS) [37].
All clients were offered behavioural support delivered by
trained advisors based on national guidelines and pharma-
cotherapy (NRT and varenicline) during their quit attempt.
About 5% of clients who attended nine services (Bristol,
County Durham and Darlington, Hull and East Riding,
Leicestershire County and Rutland, North and North East
Lincolnshire, Northamptonshire, Oldham, Rotherham and
South East Essex) between March 2012 and March 2013 were
enrolled. Data from the 3057 clients who were enrolled to the
ELONS study were included in the analysis.
Stop smoking service practitioners were asked to recruit
clients to the study. If clients consented to be part of the
study, monitoring data collection was enhanced compared
with normal practice. Clients were asked to set a quit date and
if they reported to their practitioner that theywere quit at four
weeks, they were followed up at 52 weeks by a social research
company (TNS-BMRB) through a telephone interview. If
they reported they did not quit they were assumed to be
relapsed at 52 weeks. Clients lost to follow-upwere also coded
as smoking in an intention to treat approach.
If clients indicated that they quit they were asked to
complete a carbon monoxide (CO) breath test during a
home visit and whether they had smoked since their quit
date. The outcome variable was CO validated continuous
abstinence but clients were allowed to have smoked up to five
cigarettes. Data collection complied with the Russell standard
commonly used in smoking cessation studies [38–41].
Weighting was undertaken to correct for nonresponse.
In order to create the weights, the research team acquired
anonymised routine monitoring data on all quit attempts
(with quit dates) that took place at the nine study sites from
March 2012 to March 2013 (the months where any ELONS
client set a quit date). Applying weights enabled quit rates to
be generalizable to all clients who were supported by the nine
services that took part in ELONS.The weights were trimmed
rim weights which were provided by TNS-BMRB and took
into account behavioural support type, age, gender, and SES
(measured by NS-SEC [42]). Note that the “other/unclear”
group of behavioural support in ELONS was too small for
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weighting so quit attempts in this group were redistributed
to either the nearest group or the group of which they were
most likely to be amember (three quit attempts toGPpractice
service and the remainder to one to one specialist). We
intended to also weight for location (study site) but there
were large differences in proportions recruited by location
which led to instability in the weighting and so the decision
was made to exclude this. As an alternative, quit rates were
calculated taking into account clustering by location. The
software used to create these weighted quit rates was Stata
[43]. Note that wide confidence intervals resulted from the
weighting procedure as found elsewhere when the variance
between groups is large [44, 45].
2.2. Measures. Two measures of SES were already included
in routine monitoring data collection: eligibility for free
prescriptions (a measure of income) and economic status
(through NS-SEC [42] which codes type of occupation
for respondents with a job and reasons for not working
for others). Through the enhanced monitoring data, three
more SES indicators were collected: housing tenure, highest
educational qualification, and household type. These were
added because they are common measures of SES and they
correspond tomaterial capital, human capital, and social cap-
ital, respectively. To derive a composite measure of SES, the
five indicators of SES were divided into two categories, one
of which included clients who were disadvantaged according
to that indicator. The disadvantaged categories were social
or private renter, eligible for free prescriptions, routine or
manual occupation or unemployed or permanently sick,
basic (GCSE) or no educational qualifications, and single
parent household. The number of these disadvantaged char-
acteristics possessed by each client was counted. Clients
possessed between zero and five of these characteristics. This
count of indicators was dichotomised into more affluent
(zero to one indicators) and more disadvantaged (two to
five indicators). The low cut off point was chosen for two
reasons. First, some population groups were only affected by
some indicators; for example, all clients aged sixty or more
were eligible for free prescriptions and men are less likely to
be single parents. Second, this cut point provided adequate
sample sizes for analysis.
Demographic variables included age, gender, and ethnic-
ity. Age at first contact was included in the analysis. Ethnicity
was categorised as white British, other white, Asian (includ-
ing mixed white and Asian) and other. To assess wellbeing,
following standard practice, theWHO-5Wellbeing scale [46]
items were converted to a percentage. Thus, a score of 0
indicates the lowest wellbeing and a score of 100 represents
the highest wellbeing.
Stop Smoking Services’ behavioural support provision
can either be provided through “specialist” or “level 2”
services by trained practitioners. Specialist practitioners are
directly employed by the stop smoking services and only
provide stop smoking support. Level 2 services involve staff
employed by other organisations (chiefly GP practices and
pharmacies) who provide stop smoking support alongside
their other duties. The behavioural support types analysed
were specialist groups, specialist drop ins, specialist one to
one, level 2 GP practice/pharmacy service (note this is chiefly
one to one), and other/unknown.
Seasonality effects were included because our previous
work [47] suggested that the success of quit attempts varied
throughout the year with quit attempts in the new year being
particularly successful. Such effects were analysed in this
analysis through the time of year that a quit attempt started.
Quit attempts which started during themain summer holiday
period, the postsummer holiday “back to school” period
and the new year were differentiated from those starting
at other times of year. Medication was operationalised by
whether or not clients had taken varenicline at week one.
NRT was not differentiated because of multicollinearity
with behavioural support (due to site choices of types of
medication and behavioural support provision provided).
Varenicline at week one was measured because abstinence
from smoking was strongly associated with higher numbers
of records of smoking medication and clients who had more
records had more opportunity to change medication.
Initial analysis of dependence showed that high daily
consumption and smoking within five minutes of waking
were associated with low quit rates. However, there was
not a linear relationship between either of these variables
and quitting. Thus, the Heaviness of Smoking Index (HSI)
was only of borderline significance in preliminary analysis
[37] and concerns arose that the true importance of being
dependent might be missed if the HSI was used to represent
dependence so instead a dichotomous variable was used:
clients who smoked >30 cigarettes per day or who smoked
within five minutes of waking were coded as dependent and
contrasted with all other clients.
Clients who stated that their spouse or partner was
supporting them during their quit attempt were also differ-
entiated from other clients as were clients who indicated that
half, a few, or none of their friends and family smoked.
2.3. Analysis
2.3.1. Which Markers of SES Predicted Smoking Cessation?
To provide an understanding of the components of our
composite measure of SES, weighted quit rates (and 95%
confidence intervals) were calculated for each of the five
markers of SES: eligibility for free prescriptions, NS-SEC,
housing tenure, educational qualifications, and household
type.
2.3.2. Which Predictors of Cessation Were Associated with
SES? Elsewhere [37], we have used multivariate logistic
regression to model significant predictors of CO validated
quitting 52 weeks after clients set a quit date. Here, we have
calculated weighted disadvantage rates (and 95% confidence
intervals) for each categorical characteristic that predicted
quitting and weighted means of more affluent and more
disadvantaged clients (and 95% confidence intervals) for the
characteristics operationalised through continuous variables.
We also present weighted quit rates and weighted means of
quitters and nonquitters (and 95% confidence intervals).
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Table 1: Distribution and CO validated quit rates among SES indicators.
𝑁 % % CO validated quit at 52 weeks (weighted)
NSSEC–economic status
Routine and manual occupations∗ 939 30.7 6.5 (4.7 to 8.9)
Managerial/professional and intermediate occupations 716 23.4 9.3 (6.0 to 14.0)
Sick/disabled and never worked/long term unemployed∗ 660 21.6 6.8 (4.7 to 9.9)
Other (e.g., retired)/unknown 742 24.3 8.5 (6.6 to 10.8)
Highest educational qualification
Basic (GCSE) or none∗ 1452 47.5 7.1 (5.5 to 9.3)
Other (e.g., vocational)/unknown 1000 32.7 8.2 (5.8 to 11.6)
A level or degree 605 19.8 8.6 (6.0 to 12.1)
Eligibility for free prescriptions
Free∗ 1433 46.9 6.3 (5.1 to 7.9)
Pays 1080 35.3 8.4 (6.1 to 11.4)
Outside relevant age range (19–59) or unknown 544 17.8 9.7 (7.6 to 12.5)
Housing tenure
Social/private renting∗ 1487 48.6 6.1 (4.9 to 7.4)
Other/unknown 316 10.3 4.1 (1.3 to 12.6)
Owner occupier 1254 41.0 10.8 (9.3 to 12.5)
Household type
Single parent∗ 309 10.1 5.1 (2.3 to 10.9)
Married/cohabiting and children 664 21.7 9.4 (5.8 to 14.8)
No children in household 1832 59.9 7.9 (7.0 to 8.9)
Other/unknown 252 8.2 4.7 (1.6 to 13.3)
Total 3057 100.0 7.7 (6.6 to 9.0)
∗These categories were included in the count of markers of disadvantage.
2.3.3. Did Any Predictors of Cessation Explain Any of the Rela-
tionships between SES and Abstinence from Smoking? SPSS
version 22 was used for regression analysis. Confounders for
the relationship between SES and cessation were identified
by the following procedure. First, SES was entered alone
into a logistic regression model predicting quitting and
the odds ratio of more affluent clients (compared to more
disadvantaged clients) was noted. Second, design variables
(behavioural support type) were added to the model. These
reflected differential recruitment and the model would not
provide generalizable results without their inclusion. Again
the odds ratio of more affluent clients was noted. Third,
all other variables that had previously been identified as
significant predictors of cessation [37] were entered and the
odds ratio of more affluent clients was noted. Then, each
significant predictor in the full model was removed in turn
and the odds ratio of more affluent clients was noted.
The difference between the odds ratio of more affluent
clients in the design variable model and the final model was
calculated. The threshold for a variable being a confounder
between SES and quitting was set as reducing the difference
by more than 10%.
3. Results
3.1. Which Markers of SES Predict Smoking Cessation? Quit
rates by each marker of SES are presented in Table 1 in
order to explore the components of our compositemeasure of
SES. Confidence intervals overlapped for all economic status
groups, suggesting differences were not significant; we could
not be sure the difference found would be similar in the
population, although clients with managerial/professional
and intermediate occupations did have higher quit rates.
Clients with routine and manual occupations or who were
unemployed or permanently sick had similar (lower) quit
rates.
Confidence intervals overlapped for all education cat-
egories (again suggesting differences were not significant)
but quit rates were in the expected direction: clients with
basic or no qualifications had the lowest quit rates and
clients with A levels or tertiary education had the highest.
Clients eligible for free prescriptions had the lowest quit rates.
The highest quit rates were for those outside the relevant
age group, possibly because older clients, who may also
have reached the age where they become eligible for free
prescriptions in England, irrespective of income, are more
likely to stop smoking. Confidence intervals did not overlap
between clients living in rented accommodation and clients
who lived in owner occupied housing suggesting that the
latter clientswere significantlymore likely to quit. Confidence
intervals overlapped between all household types suggesting
no significant differences. Clients who did not answer this
question or had a nonspecified household type were least
likely to stop smoking followed by single parents. Note that
only ten percent of the sample could be categorised as single
parents.
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Table 2: ELONS 52-week weighted CO validated quit rates (percents and weighted 95% CI), weighted means of age and wellbeing (and
weighted 95% CI) by key variables∗.
𝑁 %
% CO validated quit at 52 weeks % disadvantaged
(95% CI) (95% CI)
(weighted) (weighted)
SES
0-1 indicators of disadvantage 1123 36.7 10.3 (8.4 to 12.7) 0
2–5 indicators of disadvantage 1934 63.3 6.2 (5.0 to 7.7) 100
Behavioural support
Group specialist 652 21.3 12.1 (10.5 to 13.8) 57.5 (46.8 to 67.6)
Drop in specialist 887 29.0 7.6 (5.1 to 11.0) 70.3 (63.7 to 76.2)
One to one specialist 1131 37.0 10.2 (7.6 to 13.7) 64.1 (55.0 to 72.2)
GP practice/pharmacy service 366 12.0 5.1 (2.8 to 9.3) 60.1 (53.7 to 66.2)
Other or unknown 21 .7 Not available Not available
Time of year of quit attempt
Other months 767 25.1 7.0 (5.2 to 9.4) 61.7 (55.3 to 67.6)
Summer: July, August 970 31.7 6.3 (4.4 to 8.9) 64.3 (56.4 to 71.5)
Back to school: September, October 1128 36.9 8.7 (6.4 to 11.7) 65.6 (61.1 to 69.8)
New Year: January, February 192 6.3 13.1 (5.1 to 29.6) 51.5 (29.5 to 73.0)
Age (in years) Not quit 43.3 (42.5 to 44.1) 2–5 disad. 41.2 (39.7 to 42.7)
(weighted mean) Quit 46.8 (44.4 to 49.2) 0-1 disad. 47.7 (45.5 to 49.9)
Gender
Female 1710 55.9 7.2 (6.0 to 8.5) 64.0 (59.6 to 68.2)
Male 1347 44.1 8.4 (6.8 to 10.2) 62.4 (56.1 to 68.3)
WHO 5Wellbeing Not quit 52.7 (51.4 to 53.9) 2–5 disad. 51.3 (47.5 to 55.2)
(weighted mean) Quit 59.3 (56.5 to 62.1) 0-1 disad. 56.4 (52.5 to 60.3)
Medication in week 1
Varenicline not recorded 1661 54.3 6.2 (4.9 to 7.7) 66.3 (60.7 to 71.5)
Took varenicline 1396 45.7 10.0 (7.2 to 13.8) 58.8 (50.8 to 66.4)
Dependence
Other 1681 55.0 9.8 (7.7 to 12.4) 57.9 (53.2 to 62.4)
Highly dependent 1376 45.0 4.9 (2.9 to 8.2) 70.5 (65.9 to 74.7)
Support from spouse partner
Other 1507 49.3 6.2 (4.5 to 8.5) 67.1 (60.7 to 72.9)
Support from spouse/partner 1550 50.7 9.2 (7.4 to 11.3) 59.6 (54.3 to 64.6)
Friends and family
Other 771 25.2 3.4 (2.6 to 4.4) 75.2 (66.5 to 82.3)
Half or fewer smoke 2286 74.8 9.1 (7.5 to 10.9) 59.5 (55.3 to 63.6)
Base 3057 100 7.7 (6.6 to 9.0) 63.3 (58.7 to 67.6)
∗Significant differences in SES but not quitting by location (not shown).
Thus, the only marker of SES where confidence intervals
between the highest SES group and the lowest SES group did
not overlap was housing tenure. The disadvantaged category
with the lowest cessation rate was single parents (weighted
quit rate 5.1% (95% CI 2.3 to 10.9)) and the affluent category
with the highest quit rate was owner occupiers (weighted quit
rate 10.8% (95% CI 9.3 to 12.5)).
The cessation rates of the more affluent smokers and
disadvantage smokers (from the derived variable where
indicators of disadvantage were counted) are presented in
Table 2. Confidence intervals of the cessation rates for affluent
and disadvantaged smokers did not overlap (more affluent
10.3% (95% CI 8.4 to 12.7) and more disadvantaged 6.2%
(95% CI 5.0 to 7.7)) suggesting a significant difference be-
tween SES groups.
3.2. Which Predictors of Cessation Are Associated with SES?
Before analysis to find intermediate variables on the pathway
between SES and smoking cessation, bivariate relationships
between each candidate with firstly quitting and secondly SES
should be considered.The quit rates and rates of disadvantage
for each characteristic are presented in Table 2.
Confidence intervals overlapped, suggesting no signifi-
cant difference, for the following variables: behavioural sup-
port type and location (thereweremore disadvantaged clients
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Table 3: 52-week adjusted odds ratios (and 95% CI) by key variables and OR (95% CI) of disadvantaged SES is models varying the entry of
other variables.
Adjusted odds ratios in full model
Odds ratio (95% CI) of CO validated
quitting for low SES clients (2 to 5
indicators of disadvantage) compared to
more affluent clients (0 to 1 indicators of
disadvantage)
SES only entered 1.93 (1.51 to 2.47)
Design variable∗ model 1.85 (1.44 to 2.38)
SES
0-1 indicators of low SES 1.4 (1.1 to 1.9) 1.44 (1.11 to 1.87)
2–5 indicators of low SES 1
Age (in years)∗ 1.011 (1.002 to 1.020) 1.52 (1.18 to 1.97)
Gender 1.43 (1.10 to 1.86)
Female 1
Male 1.2 (0.9 to 1.5)
Seasonality 1.43 (1.10 to 1.86)
Other months 1.2 (0.8 to 1.7)
Summer: July, August 1
Back to school: September, October 1.2 (0.9 to 1.6)
New Year: January, February 1.7 (1.0 to 2.9)
Wellbeing 1.007 (1.0003 to 1.013) 1.47 (1.13 to 1.91)
Dependence 1.50 (1.15 to 1.94)
Other 1.5 (1.1 to 1.9)
Highly dependent 1
Support from spouse partner 1.47 (1.14 to 1.91)
Other 1.0
Support from spouse/partner 1.4 (1.0 to 1.8)
Social network 1.50 (1.15 to 1.95)
Other 1.0
Half or fewer smoke 2.0 (1.4 to 2.9)
Medication 1.49 (1.15 to 1.93)
Varenicline not recorded 1
Took varenicline 1.7 (1.3 to 2.3)
∗Design variable model includes behavioural support type and location due to differential recruitment.
Bold area indicates variable passed the threshold (calculated as 1.48) of being relevant in the relationship between SES and CO validated quitting.
who attended specialist drop-ins and fewer disadvantaged
clients among those who attended groups), seasonality (there
were fewer disadvantaged clients among those who started
their quit attempt in the new year), gender, wellbeing (more
affluent clients had higher levels of wellbeing than more dis-
advantaged clients), medication (fewer disadvantaged clients
took varenicline at the start of their quit attempt), and a
spouse or partner who supported the quit attempt (fewer
disadvantaged clients had a supportive spouse or partner).
Confidence intervals did not overlap, implying significant
differences, for the following variables: age (disadvantaged
clients tended to be younger), tobacco dependence (disad-
vantaged clients were more likely to be dependent), and pro-
portion of family and friends (social network) who smoked
(disadvantaged clients were less likely to say that half or fewer
of their family and friends smoked).
3.3. Did Any Predictors of Cessation Explain Any of the
Relationships between SES andAbstinence from Smoking? The
odds ratio of stopping smoking for more affluent clients with
the design variables only entered besides SES was 1.85 (1.44 to
2.38) (Table 3). This attenuated to 1.44 (1.11 to 1.87) when all
other significant predictors of quitting were added. Note that
SES is still a significant predictor of cessation. The variables
that crossed the threshold suggesting they were important in
explaining the relationship between SES and quitting were
age (OR of more affluent 1.52 (1.18 to 1.97)), dependence (OR
of more affluent 1.50 (1.15 to 1.94)), social network smoking
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(OR of more affluent 1.50 (1.15 to 1.95)), and varenicline use
(OR of more affluent 1.49 (1.15 to 1.93)).
4. Discussion
Socioeconomic disadvantage has an important role to play in
the differences in success rates in stopping smoking between
more and less affluent smokers. This study illustrates that
these differences remain even when smokers have access to
effective treatment services that are free at the point of use.
Wediscuss here themain findings of the study, aswell as some
of the limitations of the research.
4.1. Main Findings of the Study. In the introduction, we intro-
duced three types of capital pertinent to SES: material capital,
human capital, and social capital. We included measures of
SES that reflect these. The first area of investigation was the
association between these various indicators of SES and ces-
sation. The difference between housing tenures was the most
marked of the SES indicators because confidence intervals
did not overlap suggesting a significant difference. The two
main tenure categories (renting and owner occupation) both
contained over 1000 clients and the other/unknown category
was one of the smallest. This may have helped strengthen
the association. In addition there was a larger gap between
the two main tenure categories than the other SES indicators
(over four percent gap for tenure compared with less than a
two percent gap for education) suggesting the difference was
not just due to methodological reasons. Particularly marked
differences between housing tenures when compared to other
SES indicators has been found elsewhere perhaps because it
may reflect cumulative prosperity (wealth over a long time
period) [48, 49].
Housing tenure differences appearing more marked than
educational differences may suggest that it is material factors
that are more important in hindering smoking cessation
rather than human capital, cognitive or acquired skill differ-
ences betweenmore affluent andmore disadvantaged groups.
We did not look at cognitive differences in the study but
we did look at wellbeing differences. Although wellbeing
differences were found in the expected direction they were
not as marked as other factors. Our findings may also suggest
that material differences were more marked than the social
differences (between lone parent and other households, for
example). However, the small number of single parents in the
study may have reduced the valence of this measure.
In the second part of the study, we considered whether
other measured factors might affect the relationship between
SES and smoking cessation.
In terms of material capital, even though our method of
deriving the composite SES variable was intended to reduce
the age bias, age was still the strongest confounder of the rela-
tionship between SES and stopping smoking. Internationally,
evidence suggests that older people are, in general, wealthier
[50] and that younger people were disproportionally affected
by the recent global recession [51]. As smokers age the health
effects of smoking become more apparent [52] but it might
also be the case that younger smokers fail to stop smoking
due, at least in part, to the considerable stresses of material
hardship.
Human capital includes motivation. In this dataset moti-
vation did not predict cessation in the long term, possibly
because more disadvantaged smokers in the study reported
higher levels of determination to quit. We found that 64%
(95% CI 60 to 68) of more disadvantaged smokers were very
or extremely determined to quit compared with 57% (95% CI
51 to 62) of more affluent smokers.
Other human capital-related concepts were important for
cessation such as lower dependence on tobacco and taking
medication intended to help with stopping smoking. Our
results also suggest that more disadvantaged smokers were
less likely to quit because they were less likely to be offered
or take varenicline (an effective pharmacotherapy) as part of
their treatment programme.This may reflect that some of the
measures of disadvantage (particularly an economic status of
“permanently sick” and qualifying for free prescriptions) are
indicators of health disadvantage as well as socioeconomic
disadvantage. Smokers with some health conditions have
contraindications for varenicline. Conversely, an Australian
study using education, income and neighbourhood depriva-
tion as SES indicators found that low socioeconomic status
smokers were more likely to take prescription medicine
[53]. Another explanation is that practitioners within some
services in the study may have been less likely to recommend
or offer varenicline to particular groups of clients, although
this is not something we were able to explore within the data
available to us.
In terms of social capital, the results of the study are
similar to previous work that has suggested that having more
smokers in social networks (family and friends) may serve as
a barrier to smoking cessation [10].
Our analysis of measures of SES suggested factors that
reflect material disadvantage may be most important. How-
ever, our analysis of factors that confound the association
between SES and smoking suggested that human and social
issues are also relevant. Although we have split our measures
of SES and confounding variables into those that arematerial,
human, and social capital-related, in reality these factors are
interlinked. For example, tobacco dependence tends to be
higher among smokerswithmore friends and familywho also
smoke, perhaps due to higher levels of consumption through
time [54].
4.2. Limitations. This study faced a number of limitations.We
were only able to recruit a small proportion of eligible service
clients in each of the nine areas, primarily because of the
consent process required for the studywhichwas at oddswith
staff being able to introduce the research to all the smokers
they saw. We therefore attempted to address this recruitment
issue by applying weights to the data. Additionally, although
the data came from nine contrasting areas of the England,
these areas are not necessarily representative of cessation
service clients although we deliberately recruited from areas
with varying success rates [37].
Less than 10% of quit attempts in the UK involve the use
of cessation services [55] and only 5% of clients attending
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nine services were recruited to the study. Thus the evidence
in this paper only applies to a small proportion of smokers.
Nevertheless, these services are one of the most cost-effective
of all healthcare interventions [56] and evidence of the kind
outlined in this paper can contribute to expanding the reach
and effectiveness of these programmes.
Asking stop smoking service practitioners rather than
researchers to recruit may have resulted in a lower response
rate due to competing priorities. However, employing the
required number of researchers to cover nine areas would
have been expensive and was beyond the scope of the study.
In addition, we would ideally have used a more formal
mediation analysis but given the need for weighting, a
dichotomous outcome andmulticategory design variables no
such methodology was found to be suitable. Furthermore
our comparisons of quit rates and rates of disadvantage are
somewhat exploratory because we did not undertake formal
tests of differences for similar reasons.
The factors included in themodelling were unable to fully
explain the relationship between SES and smoking. In future,
studies should compare and contrast material, cognitive,
and psychological consequences of deprivation for smoking
cessation in order to understand how lower SES smokers can
be helped to maintain abstinence from smoking in the long
term.
5. Conclusion
Findings from this evaluation of longer term outcomes for
smokers enrolled in a national cessation service suggest
that these types of services face a number of challenges in
supporting more disadvantaged smokers to quit. Most of the
barriers identified relate to the individual circumstances of
these smokers. Services need to be able to identify these
factors and, if appropriate, tailor behavioural support to help
address them in some measure. In addition, higher levels
of tobacco dependence amongst these smokers should be
recognised and treated with appropriate provision of and
advice around pharmacotherapy including, importantly, use
of varenicline where available. There is also an ongoing need
to link cessation programmes with wider tobacco control
measures that support disadvantaged populations to change
behaviour. Some of the more effective policies should focus
onhowmaterial hardship can be alleviated alongside promot-
ing smoking cessation. Our results also highlight the need for
further research, in particular to explorewhy specificmarkers
of socioeconomic status, such as housing tenure, serve as
a predictor of abstinence from smoking after accessing a
treatment programme.
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